IGF1R/IR Mediates Resistance to BRAF and MEK Inhibitors in BRAF-Mutant Melanoma.

Cancers (Basel) · 2021 · PMC8616282 · PMID 34831014

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

approached significanceno p-value reported

Comparison of survival for patients with high levels of IGF1R versus low levels of IGF1R approached significance with a p -value of 0.0723.

also in 8,237 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.